Diabetes News

For adults with prediabetes, vitamin D was effective in decreasing diabetes risk, according to results of a systematic review and meta-analysis published in Annals of Internal Medicine.

Findings from a meta-regression analysis indicated that the beneficial effects of SGLT2 inhibition on CV death and HF hospitalization in patients with diabetes may be related to body weight.

Young children with type 1 diabetes who used an advanced hybrid closed-loop insulin delivery system had a reduction in HbA1c and improvement in time in range from baseline to 12 weeks, according to study data.

Adults with type 2 diabetes who use proton pump inhibitors have a higher risk for coronary artery disease, myocardial infarction, heart failure and all-cause mortality than nonusers, according to data from the UK Biobank.

A first-in-class duodenal mucosal resurfacing therapy is associated with reductions in HbA1c and body weight at 24 weeks among a cohort of insulin-treated adults with type 2 diabetes, according to a company press release.

Researchers highlighted challenges with continuous glucose monitoring devices, including trouble interpreting results, device adhesion and smartphone access, among adults aged 50 to 85 years with type 1 or type 2 diabetes.

Health insurance policy changes that expand access to continuous glucose monitoring for adults with type 1 or type 2 diabetes can greatly increase uptake of the devices, according to a study published in Diabetes Technology & Therapeutics.

A strong correlation exists between time below range of 54 mg/dL and time below range of 70 mg/dL, though the difference between the two values varies based on continuous glucose monitoring type, according to study data.

Maintaining a healthy lifestyle — before or after type 2 diabetes diagnosis — was associated with significantly lower risk for microvascular complications for people with the disease, according to study data.

An ED screening program identified patients with undiagnosed prediabetes and type 2 diabetes or undermanaged disease, particularly among racial and ethnic minorities and patients with low income, researchers reported in JAMA Network Open.